These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 16027229

  • 1. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C, Cialdai C, Giuliani S, Lecci A, Tramontana M, Meini S, Quartara L, Maggi CA.
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [Abstract] [Full Text] [Related]

  • 2. MEN16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways.
    Valenti C, Cialdai C, Giuliani S, Tramontana M, Quartara L, Maggi CA.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):350-6. PubMed ID: 18036587
    [Abstract] [Full Text] [Related]

  • 3. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
    Cialdai C, Giuliani S, Valenti C, Tramontana M, Maggi CA.
    J Pharmacol Exp Ther; 2009 Dec 28; 331(3):1025-32. PubMed ID: 19745108
    [Abstract] [Full Text] [Related]

  • 4. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P, Meini S, Bressan A, Catalani C, Bellucci F, Santicioli P, Lecci A, Faiella A, Rotondaro L, Giuliani S, Giolitti A, Quartara L, Maggi CA.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):7-16. PubMed ID: 16324696
    [Abstract] [Full Text] [Related]

  • 5. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
    Tramontana M, Lecci A, Meini S, Montserrat X, Pascual J, Giuliani S, Quartara L, Maggi CA.
    J Pharmacol Exp Ther; 2001 Mar 28; 296(3):1051-7. PubMed ID: 11181940
    [Abstract] [Full Text] [Related]

  • 6. Bradykinin-induced lung inflammation and bronchoconstriction: role in parainfluenze-3 virus-induced inflammation and airway hyperreactivity.
    Broadley KJ, Blair AE, Kidd EJ, Bugert JJ, Ford WR.
    J Pharmacol Exp Ther; 2010 Dec 28; 335(3):681-92. PubMed ID: 20847038
    [Abstract] [Full Text] [Related]

  • 7. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
    Griesbacher T, Legat FJ.
    Br J Pharmacol; 1997 Mar 28; 120(5):933-9. PubMed ID: 9138701
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.
    Fattori D, Rossi C, Fincham CI, Caciagli V, Catrambone F, D'Andrea P, Felicetti P, Gensini M, Marastoni E, Nannicini R, Paris M, Terracciano R, Bressan A, Giuliani S, Maggi CA, Meini S, Valenti C, Quartara L.
    J Med Chem; 2007 Feb 08; 50(3):550-65. PubMed ID: 17266207
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM, Calixto JB.
    Br J Pharmacol; 1998 Jan 08; 123(2):281-91. PubMed ID: 9489617
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
    Meini S, Cucchi P, Catalani C, Bellucci F, Giuliani S, Santicioli P, Maggi CA.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):10-6. PubMed ID: 19445925
    [Abstract] [Full Text] [Related]

  • 11. S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivo.
    Félétou M, Robineau P, Lonchampt M, Bonnardel E, Thurieau C, Fauchère JL, Widdowson P, Mahieu JP, Serkiz B, Volland JP.
    J Pharmacol Exp Ther; 1995 Jun 01; 273(3):1071-7. PubMed ID: 7791077
    [Abstract] [Full Text] [Related]

  • 12. Effect of Hoe 140 on bradykinin-induced bronchoconstriction in anesthetized guinea pigs.
    Wirth KJ, Gehring D, Schölkens BA.
    Am Rev Respir Dis; 1993 Sep 01; 148(3):702-6. PubMed ID: 8368643
    [Abstract] [Full Text] [Related]

  • 13. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S, Lecci A, Cucchi P, Catalioto RM, Criscuoli M, Maggi CA.
    J Pharmacol Exp Ther; 1998 Oct 01; 287(1):137-43. PubMed ID: 9765332
    [Abstract] [Full Text] [Related]

  • 14. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T, Sametz W, Legat FJ, Diethart S, Hammer S, Juan H.
    Br J Pharmacol; 1997 Jun 01; 121(3):469-76. PubMed ID: 9179388
    [Abstract] [Full Text] [Related]

  • 15. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
    Asano M, Inamura N, Hatori C, Sawai H, Fujiwara T, Katayama A, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Nakahara K, Oku T, Okuhara M.
    Br J Pharmacol; 1997 Feb 01; 120(4):617-24. PubMed ID: 9051299
    [Abstract] [Full Text] [Related]

  • 16. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
    Félétou M, Lonchampt M, Robineau P, Jamonneau I, Thurieau C, Fauchère JL, Villa P, Ghezzi P, Prost JF, Canet E.
    J Pharmacol Exp Ther; 1995 Jun 01; 273(3):1078-84. PubMed ID: 7791078
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
    Meini S, Lecci A, Carini F, Tramontana M, Giuliani S, Maggi CA, Ricci R, Fabbri G, Anichini B, Harmat N, Rizzi A, Camarda V, Regoli D, Quartara L.
    Can J Physiol Pharmacol; 2002 Apr 01; 80(4):293-302. PubMed ID: 12025964
    [Abstract] [Full Text] [Related]

  • 18. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
    Majima M, Kawashima N, Hiroshi I, Katori M.
    Br J Pharmacol; 1997 Jun 01; 121(4):723-30. PubMed ID: 9208140
    [Abstract] [Full Text] [Related]

  • 19. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S, Quartara L, Rizzi A, Patacchini R, Cucchi P, Giolitti A, Calò G, Regoli D, Criscuoli M, Maggi CA.
    J Pharmacol Exp Ther; 1999 Jun 01; 289(3):1250-6. PubMed ID: 10336513
    [Abstract] [Full Text] [Related]

  • 20. Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
    Hayashi I, Ishihara K, Kumagai Y, Majima M.
    Br J Pharmacol; 2001 Aug 01; 133(8):1296-306. PubMed ID: 11498515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.